Correlation Between Mineralys Therapeutics, and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Ikena Oncology, you can compare the effects of market volatilities on Mineralys Therapeutics, and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Ikena Oncology.
Diversification Opportunities for Mineralys Therapeutics, and Ikena Oncology
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Mineralys and Ikena is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Ikena Oncology go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Ikena Oncology
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Ikena Oncology. In addition to that, Mineralys Therapeutics, is 3.91 times more volatile than Ikena Oncology. It trades about -0.05 of its total potential returns per unit of risk. Ikena Oncology is currently generating about -0.01 per unit of volatility. If you would invest 172.00 in Ikena Oncology on August 27, 2024 and sell it today you would lose (1.00) from holding Ikena Oncology or give up 0.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Ikena Oncology
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Ikena Oncology |
Mineralys Therapeutics, and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Ikena Oncology
The main advantage of trading using opposite Mineralys Therapeutics, and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| Ikena Oncology vs. Eliem Therapeutics | Ikena Oncology vs. HCW Biologics | Ikena Oncology vs. Scpharmaceuticals | Ikena Oncology vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets |